Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street’s expectations.
The company said that sales range reflects a decision to halt shipments of Gardasil, a vaccine that prevents cancer from HPV, into China beginning in February and going through at least mid-2025.
